Yazar "Yazici, Selma" seçeneğine göre listele

Listeleniyor 1 - 5 / 5
  • [ X ]
    Öğe
    THE ASSESMENT OF CARDIAC SEMPATOVAGAL ACTIVITY BY HEART RATE VARIABILITY IN PATIENTS WITH RHEUMATOID ARTHRITIS
    (Oxford Univ Press, 2011) Cevik, Figen Ceylan; Yazici, Selma; Cil, Habib; Cevik, Remzi; Sarac, Aysegul Jale; Nas, Kemal
    [Abstract Not Available]
  • [ X ]
    Öğe
    The gastrocnemius muscle hematoma arising from warfarin use: The importance of genotype analysis in hematomas of atypical localization
    (Baycinar Medical Publ-Baycinar Tibbi Yayincilik, 2012) Atilgan, Zuhal Ariturk; Tekbas, Ebru Onturk; Atilgan, Serhat; Yazici, Selma; Yavuz, Celal
    Warfarin is an effective anticoagulant which is used for the prevention of arterial and venous thrombosis. Currently, this type of oral anticoagulant drugs are often used with various indications and rarely leads life-threatening bleeding. Although bleeding into the gastrocnemius muscle, is usually associated with trauma, it may very rarely result from warfarin overdose. In this article, we report a-41-year-old female case with hematoma in the gastrocnemius muscle due to low doses (i.e. 1.25 mg) of warfarin every other. day.
  • [ X ]
    Öğe
    Metabolic Syndrome in Patients With Ankylosing Spondylitis
    (Elmer Press Inc, 2011) Batmaz, Ibrahim; Karakoc, Mehmet; Sariyildiz, Mustafa Akif; Yazici, Selma; Tahtasiz, Mehmet; Atilgan, Zuhal; Cevik, Remzi
    Background: The objective of this study is to investigate the presence of metabolic syndrome (MS) in patients with ankylosing spondylitis (AS) and to evaluate its relationship with the clinical parameters. Methods: Fifty patients who presented to the Dicle University School of Medicine, Physical Therapy and Rehabilitation Outpatient Clinic and were diagnosed with AS according to the 1984 New York criteria were enrolled in this study. The control group consisted of 44 healthy control subjects. Assessment of the MS was made according to the diagnostic criteria specified in the National Cholesterol Education Program Adult Treatment Panel III Report (NCEP ATP III). Functional status and disease activity were evaluated using the Bath Ankylosing Spondylitis Functional Index (BASFI) and the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) for AS. Results: MS was observed in 6 out of the 50 AS patients (12%) and in 2 out of the 44 controls (4.5%) (P > 0.05). However, the HDL cholesterol level (P = 0.006) was found as significantly lower in AS patients than the controls. No statistically significant differences were observed in the disease duration and functional and clinical activity indices between the AS patients with and without MS. Conclusions: Although the frequency of MS was observed to be higher in patients with AS than the controls in this study, the differences were statistically insignificant between the two groups.
  • [ X ]
    Öğe
    METABOLIC SYNDROME IN PATIENTS WITH ANKYLOSING SPONDYLITIS
    (Oxford Univ Press, 2011) Batmaz, Ibrahim; Karakoc, Mehmet; Yazici, Selma; Cevik, Remzi; Nas, Kemal; Sarac, Aysegul Jale; Atilgan, Zuhal
    [Abstract Not Available]
  • [ X ]
    Öğe
    Third-Degree Atrioventricular Block Due to Chloroquine Treatment
    (Baycinar Medical Publ-Baycinar Tibbi Yayincilik, 2011) Islamoglu, Yahya; Yazici, Selma; Cil, Habib; Elbey, Mehmet Ali; Atilgan, Zuhal; Tekbas, Ebru
    A 67-year-old woman on long-term chloroquine treatment for rheumatoid arthritis presented with dizziness and syncope. Although her medical history revealed no cardiovascular disease, complete atrioventricular block was detected by electrocardiography. Chloroquine was discontinued. Three days later, complete atrioventricular block spontaneously resolved to sinus rhythm. Cardiac complications associated with chronic chloroquine use are uncommon, nevertheless, there have been several reports on potential life-threatening rhythm disturbances and/or cardiomyopathy. In our case, atrioventricular block was associated with chronic chloroquine use. Cardiac evaluation with electrocardiography must be done for conduction disorders in patients using chloroquine for rheumatic diseases. Turk J Phys Med Rehab 2077;57:253-5.